Atonarp's Aston Impact Metrology Platform Starts Volume Shipments to Semiconductor FABs in Korea
PR95303
TOKYO, Apr. 4, 2022 /PRNewswire=KYODO JBN/--
Atonarp (
), the leader in in-situ, real-time high-sensitivity metrology for
semiconductor process control, announces worldwide release for sale of its
Aston (
) platform. This marks an important milestone in the Company's transition to a
commercial organization on a worldwide scale.
Photo - https://mma.prnewswire.com/media/1778470/Atonarp_Aston_Impact.jpg
Logo - https://mma.prnewswire.com/media/1573283/Atonarp_Logo.jpg
Aston is a compact mass spectrometer that provides accurate, real-time data on
the process chemistry with sensitivity to measure the molecular concentrations
down-to parts per billion. This data enables semiconductor manufacturing FABs
to run more efficiently, thus increasing the yield and throughput, delivering
dramatic financial benefits to FAB operators.
With today's announcement, Atonarp is shipping production orders of Aston
Impact to leading semiconductor FABs and equipment manufacturers in Korea and
the USA. It is also shipping dozens of Aston units for clients' evaluations in
their advanced processes to optimize their process and manufacturing
efficiencies.
"The ability to rapidly detect, quantify and provide actionable process control
data at a molecular level is a real game changer in advanced semiconductor
manufacturing processes," said Martin Mason, VP of Product Marketing at
Atonarp. "Even a one percent increase in throughput can add up to tens of
millions of dollars a year in production for a typical FAB. Aston is seeing
significant traction where speed with sensitivity matter to molecular level
process control efficiency."
Metrology is a vital part of semiconductor manufacturing. The concentration of
multiple gases is measured within production equipment to ensure process
margins are met while minimizing waste. Previous solutions have relied on
optical emission spectroscopy and residual gas analyzers, but these legacy
methods cannot provide the speed and sensitivity required for today's advanced
memory and logic processes. Instead, Aston uses innovative mass spectroscopy
technology, with a best-in-class sensor, to provide fast results with excellent
sensitivity, as well as the robustness needed to resist corrosive gases and
condensates.
Aston provides actionable data for advanced semiconductor applications such as
atomic level deposition (ALD) and sub-fab operations. At less than nine parts
per billion square root of Hertz (9ppb square root Hz), Aston offers up to ten
times better sensitivity than competitors' solutions, without compromising on
the speed at which data can be gathered.
Atonarp is actively engaged in partnerships to develop the Aston platform for
new applications within the semiconductor space as well as for applications
where real-time, sensitive gas analysis is needed, such as Oil & Gas and
lyophilization process control.
Aston has achieved multiple certifications and qualifications, EN55032 (EU), EN
55035 (EU), FCC part 15 (US), ICES-003 (Canada), VCCI CISPR-32 (Japan), BSMI
(Taiwan), KC EMC (Korea) for EMI/EMC compliance. With these certifications
Aston is now being shipped in volume to customers worldwide.
Atonarp has partnered with ATI Korea to provide integrated solutions for Etch,
CVD, Spatial ALD and Sub-fab applications to customers in the region.
For more information on the Atonarp Aston family of products please visit:
About Atonarp
Atonarp is advancing clinical diagnostics, life science research,
semiconductor, and industrial process control through digital molecular
profiling. Our Aston and ATON platforms harness the power of innovative
spectrometry technologies with advanced analytics to generate real-time,
actionable results. Our platforms can be applied to a wide variety of
applications across multiple industries. In-situ, highly sensitive molecular
metrology in advanced manufacturing processes means higher throughput, improved
efficiency, and reduced waste. Our quantitative, multiplex chemistry-free
diagnostic tests enable disease diagnosis and monitoring at the point-of-care,
which can improve outcomes and patient satisfaction at lower cost.
SOURCE: Atonarp
CONTACT: Cynthia Hoye, ch@embedded-pr.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。